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INTRODUCTION
Otitis media with effusion (OME) is a disease that’s characterized
by the presence of fluid in the middle ear. Despite the substantial
investigation that has been done on OME, the precise etiology
and pathogenesis of OME still remains unclear. Immune disturban-
ces and Eustachian tube dysfunction are considered to be most
important contributing factors. Several cytokines, including inter-
leukin-1beta (IL-1b), IL-8 and tumor necrosis factor-alpha (TNF-
a), and complement C3 are considered to play key roles in the
initiation and maintenance of the inflammatory response in OME
(1-3). Other allergy-related pathomechanisms may underlie OME.
The Th-2-driven cytokines IL-4, IL-6, and TNF-a may contribute
to the allergy-related persistence of OME (4). More knowledge
concerning the pathomechanisms of OME and the contributing
cytokines is needed to develop truly efficacious treatment and
prevention strategies. 
Heat shock proteins (HSPs) are essential for the survival of cells
that are undergoing environmental stress. Various families of
HSPs, including HSP90, HSP70, HSP60, and HSP27, have been
categorized based on their molecular weights and functional attri-
butes (5). Their synthesis is enhanced by exposure to a variety
of detrimental conditions such as heat, toxins, oxidative stress and
glucose deprivation (6). HSP70 is expressed in the middle ear mu-
cosa of experimentally induced acute otitis media (AOM) (7, 8).
Even though it has been considered that HSPs mainly function
as molecular chaperones, they also appear to be involved in diver-
se biological activities such as apoptosis, carcinogenesis and cyto-
protection from cytotoxic damage. The cytoprotective role of HSP
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synthase (iNOS) has recently been studied in gastritis induced by
the pathogenic bacterium helicobacter pylori (9). The latter study
is intriguingly germane to otolaryngology because of the similar
pathomechanisms that are involved in the iNOS pathway. In an-
other study, the proteomic analysis of murine skin demonstrated
that HSP70 is an important mediator of allergic contact hypersens-
itivity, which indicates that inhibiting its activity may be benefi-
cial for preventing autoimmune and immunological hypersensi-
tivity diseases (10).
Considering its confounding effect on various inflammatory
processes, HSP70 may well be important in the pathoetiology
of diseases that affect different organs, or at different stages of a
disease. To the best of our knowledge, there have been no pub-
lished reports concerning the expression and the possible role
of HSP70 in the middle ear effusion (MEE) of humans during
the disease process of OME. Here we report for the first time
on the expression of HSP70 in human MEE and its possible role
in the chronicity of OME as an inflammatory mediator or indi-
cator.
MATERIALS AND METHODS
Subjects
A total of 30 ears from children aged 9 months to 15 yr (mean
age, 4.1±3.6 yr) and who had chronic OME for more than 2
months (range, 2 to 10 months) and 38 ears from adults who
were medically treated and observed for their OME for at least
1 month and who were undergoing myringotomy or tympano-
tomy tube placement at Seoul St. Mary’s Hospital were includ-
ed in this study. The study has been approved by the Institutional
Review Board of the Catholic Medical Center (Seoul St. Mary’s
Hospital). The adults were subgrouped according to their previ-
ous history of head and neck region radiation therapy (received
or not received) as their concomitant cancer treatment to observe
the difference in the cytokine and HSP70 expressions in the MEE
between the two groups. 
Collection of the MEE
To collect the various types of the MEE without any loss, we de-
signed a MEE sampling system that consisted of a 1 cc tuberculin
syringe, a long and thin intravenous (i.v.) catheter and different
sizes of blunt spinal needles (17-23 G), as shown in Fig. 1. The
amount of the effusion was directly measured within the syringe.
The nature of the fluid (serous, mucous or seromucous) was deter-
mined by the attending surgeon. Serum-like yellowish clear fluid
without any viscosity was considered as serous, and thick viscous
fluid that was hard to collect was considered as mucous. The fluid
that contained both of serous and mucous components was con-
sidered as seromucous. The collected MEE was stored at -70℃
until it was used.
Collection of the clinical data and the audiologic tests
The clinical data concerning OME was obtained from the parti-
cipants by using a specially designed questionnaire. The informa-
tion obtained included the frequency of tympanostomy tube in-
sertion, the duration of OME and the allergy history of each pa-
tient. An audiology test measuring the pure tone averages of the
air and bone conduction hearing levels at the speech frequency
was performed preoperatively for most of the patients. 
Measurements of the total protein, TNF-a, IL-1b and
HSP70 levels in the MEE
The total protein was assayed using a Bradford-based commer-
cial kit (BioRad, Hercules, CA, USA) with bovine serum albu-
min as a standard. The TNF-a, IL-1b and HSP70 levels in the
MEE were determined using a specific enzyme-linked immuno-
sorbant assay (ELISA) kit for human TNF-a (Biosource, Camarillo,
CA, USA), human IL-1b (R&D Systems, Minneapolis, MN, USA)
and HSP70 (Stressgen Biotechnologies, Victoria, BC, Canada)
according to the instructions of the particular manufacturer. 
Statistical analyses
One-way ANOVA, Chi-square tests and standard Pearson cor-
relation tests were used to compare the clinical data, the hearing
levels, the nature of the fluid, the total protein and the TNF-a, IL-
1b and HSP70 levels in the different groups. Statistical analyses
were done using SPSS ver. 11.5 (SPSS Inc., Chicago, IL, USA).
Statistical significance was set at P-values < 0.05.
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Fig. 1. Our middle ear effusion collection system (Park’s MEE collec-
tion system). This system, which was designed as part of the current
study, consists of a 1 mL tuberculin syringe, an 18-23 gauge blunt
spinal needle and an intravenous catheter. The backside of the sy-
ringe was connected to the catheter, and the catheter was then con-
nected to a suction tube, and the system prevents any loss of effu-
sion.20 Clinical and Experimental Otorhinolaryngology  Vol. 3, No. 1: 18-23, March 2010
RESULTS
Clinical characteristics  
The patients were 30 children (mean age, 4.1 yr), 27 adults who
had not received radiation therapy (mean age, 62.5 yr) and 11
adults who had received radiation therapy (mean age, 58 yr).
The basic demographic composition of these study groups is
shown in Table 1. The gender distribution, the duration of OME
and the hearing levels among the three different groups were not
significantly different. The number of previous tympanostomy
tube insertions was higher for the adults who had not received
radiation therapy. Almost all the effusions in the children were
mucous or seromucous in nature, whereas most of the adult effu-
sions were serous. These observations are consistent with those
previously reported for adult OME (11, 12).
The levels of HSP70 and other cytokines in the MEE
HSP70 was detected in all the MEEs in the three study groups,
but the level varied quantitatively (64±44 ng/mL for the chil-
dren, 48±32 ng/mL for the adults who had not received radia-
tion therapy and 41±33 ng/mL for the adults who had received
radiation therapy). The quantitative differences were not statis-
tically significant (Fig. 2A) The levels of TNF-a in the different
groups were also analyzed. The average concentration of TNF-
b in the MEE was 232±453 pg/mL for the children, 44±84
pg/mL for the adults who had not received radiation therapy
and 42±47 pg/mL for the adults who had received radiation
therapy (Fig. 2B). The higher TNF-a level in children was not
statistically significant (P=0.055). The IL-1bMEE level was high-
est in the children (743±931 pg/mL), followed by that in the
adults who had received radiation therapy (114±248 pg/mL)
and that in the adults who had not received radiation therapy (38
±88 pg/mL). The latter’s IL-1b MEE level was significantly dif-
ferent from that of the children (P<0.05). No other statistically
significant differences between the groups were evident for IL-1b
P-value
Adults with
RTx
(n=11)
Adults 
without
RTx (n=27) 
Children
(n=30) 
Characteristics
Table 1. The clinical profiles of the patients with otitis media with effu-
sion in this study
Values are presented as mean±SD.
*0: serous, 1: seromucous, 2: mucous. 
RTx: radiation therapy; PTA: pure tone audiogram.
Fig. 2. Comparison of heat shock protein (HSP)70, tumor necrosis
factor (TNF)-a and interleukin (IL)-1b in the different groups with otitis
media with effusion. (A) HSP70 was expressed in all the types of mi-
ddle ear effusion in the three groups. The HSP70 levels were 64±44
ng/mL in the children, 48±32 ng/mL in the adults who did not receive
radiation therapy and 41±33 ng/mL in the adults who did receive
radiation therapy. The level of HSP70 in the middle ear effusion (MEE)
of the children was slightly higher than those levels of HSP70 of the
adult groups, although the difference was not significant. (B) The
level of TNF-a in the MEE of the children was higher than those TNF-
a levels of the adults, although the difference was not statistically sig-
nificant (P=0.055). (C) The level of MEE IL-1b in the children was sig-
nificantly different from that in the adults who had not received radia-
tion treatment (P<0.05). RTx: radiation therapy.
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*
A
C
B
Age 4.1±3.6 58±17.4 62.5±9.2 <0.0001
Gender (M:F) 17:13 13:14 6:5 NS
Duration (mon) 3.0±1.9 3.6±4.6 1.5±1.0 NS
PTA 26.9±9.3 20.3±5.7 23.0±2.7 NS
(Air bone gap: dBHL)
Amount (mL) 137.7±75.5 155.8±53.5 100.0±61.2 0.201
Tube (No. of insertion) 1.2±0.8 2.8±3.1 0.5±0.6 0.03
Nature (0/1/2)* 6/10/12 18/5/4 9/2/0 <0.01Park S-N et al.: HSP70 in Human Middle Ear Effusion 21
(Fig. 2C)
HSP70s and the other cytokines in the different types of
effusion  
The levels of HSP70 in the mucous and seromucous effusions were
significantly higher than that of the serous effusion (P<0.05). A
similar phenomenon was observed for the levels of TNF-a in the
MEE (P<0.05). However, the IL-1b levels did not show any me-
aningful differences in the different types of effusion (Table  2).
Correlations between HSP70, the early cytokines and
the other clinical factors 
The HSP70 level was correlated with the levels of TNF-a(r=0.48)
and IL-1b (r=0.31) in the effusions. The highest correlation was
between two early cytokines(TNF-a and IL-1b) (r=0.62). The po-
sitive correlations between HSP70, TNF-a and IL-1b were stati-
stically significant (P<0.05). There was no correlation evident
between the level of HSP70 and age, but negative correlations
were evident between TNF-a/IL-1b and age. The levels of all
three cytokines were not significantly correlated with the amount
of MEE (Table 3). 
DISCUSSION
HSPs are crucial for the maintenance of cell integrity during both
normal cell growth and pathophysiological conditions (13). Their
expressions are induced by various conditions such as heat, oxi-
dative stress and drug exposure; the type of HSP induced and its
level of expression are responsible for the fate of a cell in response
to stress or stimulus (14). HSP70 is expressed during the inflam-
matory process of experimentally induced MEE by bacterial in-
oculation (7). However, there has been no report regarding the
HSP70 expression or its quantification in human OME. Yet given
that this protein has been detected in the middle ear mucosa of
an experimental model of AOM (7), we hypothesized that HSP70
could be expressed in the mucosa of the middle ear during the di-
sease process of human OME, and it could be secreted from the
inflamed mucosa to the MEE. The MEE HSP70 levels in the cur-
rent study were measured using ELISA and the level of this pro-
tein was compared to other well-known early onset cytokines su-
ch as TNF-a and IL-1b in the MEEs. The levels of HSP70 in hu-
man MEE and their correlations with the nature of the effusion
and the other clinical characteristics have not been previously re-
ported on. 
For the proper collection of MEE, we developed the collection
system (Park’s MEE collection system) shown in Fig. 1. This sam-
pling system is easy to assemble in the hospital setting. Moreover,
its long, thin i.v. catheter connected to the back side of a 1 mL tu-
berculin syringe enabled controlling the suction power, which
prevents loss of the MEE. A third advantage is the various sized
blunt spinal needles that are directly connected to the tuberculin
syringe, which eases the collection of different types of MEE, in-
cluding the fluid that is thick and mucous in nature. The direct col-
lection of MEE using the graded tuberculin syringe provides an
easy, accurate means of measuring the volume of the recovered
MEE. Finally, the collected MEE can be directly stored in the sy-
ringe, which lessens the possibility of contamination or the loss of
the MEE. 
The present study reports the first description of the HSP70 ex-
pression in human MEE. Indeed, HSP70 was detected in the mu-
cous, seromucous and serous MEEs. The higher level detected in
the mucous and seromucous effusions, as compared to the serous
effusion, suggests that HSP70 should be considered as another
cytokine that may be related with the chronicity of OME. HSPs
are crucial for the maintenance of cell integrity during both nor-
mal cell growth and pathophysiological conditions (13). They also
play a cytoprotective role in other mucosal tissues. For example,
those guinea pig gastric mucosal cells in which HSPs have been in-
duced by heat shock treatment can show considerable resistance
to injury induced by ethanol (15). The cytoprotective mechanism
of HSPs in various stressful conditions has been revealed by mo-
dulating the expression of an enzyme that causes tissue damage.
In rat pulmonary artery smooth muscle cells, the expression of
IL-1b-induced iNOS can be inhibited by a preinduced HSP70
expression (16). After challenge with endotoxin, the induced HSP
70 expression in the mesenteric artery, lung and liver can signifi-
cantly attenuate hypotension and it can up-regulate the iNOS m
RNA expression in rats (17). iNOS is expressed in the middle ear
Characteristics Serous Seromucous Mucous   P-value
Table 2. The levels of HSP70 and the other cytokines in the different
types of effusion
Values are presented as mean±SD.
HSP: heat shock protein; TNF: tumor necrosis factor; IL: interleukin.
HSP70 (ng/mL) 37.1±31.9 66.7±51.7 69.2±28.7 0.036
TNF-a (pg/mL) 22.2±18.6 211.8±504.1 194.8±297.7 0.049
IL-1b (pg/mL) 259.9±769.3 588.3±658.6 392.0±361.9 0.465
Correlations r P-value
Table 3. Correlations between HSP70, the early cytokines and other
clinical factors
HSP70 vs. TNF-a 0.474 <0.01
HSP70 vs. IL-1b 0.312 <0.05
TNF-a vs. IL-1b 0.617 <0.01
HSP70 vs. age -0.271 0.060
TNF- a vs. age -0.298 0.017
IL-1b vs. age -0.454 0.003
HSP70 vs. amount of MEE 0.020 NS
TNF-a vs. amount of MEE 0.031 NS
IL-1b vs. amount of MEE 0.100 NS
HSP: heat shock protein; TNF: tumor necrosis factor; IL: interleukin, MEE:
middle ear effusion.mucosa when the inflammatory reaction is initiated by various
types of insults (18, 19), and iNOS is also induced by early onset
cytokines, including IL-1b and TNF-a, in a MEE. The latter indu-
ctions might be related to the cytoprotective role of HSP70 in
OME, as was shown in other tissues. 
From the beginning of this study, we hypothesized that the MEE
in different age groups (adults and children) and in the groups with
a definitive causal factor such as Estachian tube dysfunction after
radiation therapy (adults with RT) or without a definitive causal
factor (adults without RT) might show different cytokine levels
and HSP70 levels. We found the difference of the early cytokine
expressions in the different age groups, but we could not find any
difference of the early cytokine expressions in the two different
adult groups. We could conclude that the disease process of MEE
in adults and children seemed to be different, whereas the MEE
in adults with or without RT did not seem to have a different in-
flammatory process. Since there is well known longevity of the
disease process from the serous effusion to the seromucous infu-
sion to the mucous effusion in OME, we can postulate that the na-
ture of the fluid might represent the chronicity of the disease here
in our study. The result of our study showed that HSP70 and
TNF-a were highly expressed in the mucous MEE, and that the
HSP70 level was positively correlated with the levels of TNF-a
and IL-1b. In the previous study by Nell and Grote (20), early
cytokines such as TNF-a and IL-1b were expressed at a higher
level in the mucous effusion than that in the in serous effusion,
which was the same result as ours. They concluded that the thick
and mucoid effusions are an indication of chronic disease. We
could not find any significant difference in the HSP70 level accor-
ding to the age group. These results support the contention that
the HSP70 in MEE could be a cytokine that is secreted from the
middle ear mucosa and it is a good indicator of disease chronici-
ty. Considering the positive correlation between HSP70 and
TNF-a/IL-1b we can also postulate a possible representative role
for HSP70 as a cytoprotectant of the middle ear mucosa during
OME. We can suggest the possible pathomechanism of the HSP70
expression in the MEE during the disease process of OME and its
relationship with the other early cytokines. During the early
stage of OME that is evident as serous effusion, generation and
secretion of inflammatory mediators, including TNF-a and IL-1b
might be low and so this would not lead to a high expression of
HSP70 in the middle ear mucosa. As the disease progresses, the
higher generation of the inflammatory mediators in the middle
ear mucosa would lead to the higher expression of HSP70 in the
middle ear epithelial cells and its secretion into the MEE. Future
experiments designed to investigate the iNOS expression in MEE,
which might be related to the expression of HSP70, could be
helpful for understanding the disease process of OME. Further
studies to investigate the more precise functional role of HSP70
in OME will be necessary to provide clues regarding other per-
spectives on the pathomechanism and treatment of OME. 
We performed this study to investigate the possibility of an HSP
70 expression in human MEE and to examine its potential role as
a cytokine during the disease process of OME. The study results
show that HSP70 is expressed in the various types of human MEE
and the HSP70 level is positively correlated with the levels of
other cytokines in MEE. As far as we can determine, this is the
first report on the HSP70 expression in human MEE. The high-
ly elevated level of HSP70 in the seromucous and mucous effu-
sions indicates that this protein might be related with the chronic-
ity of this disease. The specially designed MEE collection system
(Park’s MEE collection system) that was successfully used during
this study should prove to be valuable when conducting future
studies on human MEE. 
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